[HTML][HTML] Iron overload in patients with rare hereditary hemolytic anemia: evidence‐based suggestion on whom and how to screen
S van Straaten, BJ Biemond, JL Kerkhoffs… - American journal of …, 2018 - ncbi.nlm.nih.gov
S van Straaten, BJ Biemond, JL Kerkhoffs, J Gitz‐Francois, R van Wijk, EJ van Beers
American journal of hematology, 2018•ncbi.nlm.nih.gov3. Leventhal JR, Elliott MJ, Yolcu ES, et al. Immune reconstitution/immunocompetence in
recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation.
2015; 99: 288-298. 4. Amorin B, Alegretti AP, Valim V, et al. Mesenchymal stem cell therapy
and acute graft-versus-host disease: a review. Hum Cell. 2014; 27: 137-150.
recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation.
2015; 99: 288-298. 4. Amorin B, Alegretti AP, Valim V, et al. Mesenchymal stem cell therapy
and acute graft-versus-host disease: a review. Hum Cell. 2014; 27: 137-150.
3. Leventhal JR, Elliott MJ, Yolcu ES, et al. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation. 2015; 99: 288-298. 4. Amorin B, Alegretti AP, Valim V, et al. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell. 2014; 27: 137-150.
ncbi.nlm.nih.gov